| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |